Outset Medical Inc.
0.81
0.00 (0.27%)
At close: Jan 14, 2025, 3:59 PM
0.86
6.29%
Pre-market Jan 15, 2025, 04:20 AM EST
undefined%
Bid 0.78
Market Cap 43.09M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -2.74
PE Ratio (ttm) -0.3
Forward PE n/a
Analyst Buy
Ask 0.86
Volume 1,844,144
Avg. Volume (20D) 1,011,801
Open 0.80
Previous Close 0.81
Day's Range 0.76 - 0.83
52-Week Range 0.43 - 5.22
Beta undefined

About OM

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015...

Sector Healthcare
IPO Date Sep 15, 2020
Employees 480
Stock Exchange NASDAQ
Ticker Symbol OM

Analyst Forecast

According to 3 analyst ratings, the average rating for OM stock is "Buy." The 12-month stock price forecast is $3, which is an increase of 268.64% from the latest price.

Buy 66.67%
Hold 33.33%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Outset Medical Inc. is scheduled to release its earnings on Feb 19, 2025, during market hours.
Analysts project revenue of $27.79M, reflecting a -8.91% YoY shrinking and earnings per share of -0.37, making a -37.29% decrease YoY.
2 months ago · Source
+25.18%
Outset Medical shares are trading higher after the... Unlock content with Pro Subscription
5 months ago · Source
-68.53%
Outset Medical shares are trading lower after the company reported worse-than-expected Q2 financial results and cut its FY24 revenue guidance.